|
| Figure 3: Frequency of treatment-related adverse drug reactions (ADRs). Frequency of ADRs at least possibly related with the SQ grass SLIT-tablet (observed in > 1% of patients) as total ADRs at least possible related and ADRs at first administration (MedDRA preferred terms). |
